Article

Metabolic and Clinical Heterogeneity in MASLD Risk Stratification: Independent Effects of Body Mass Index and Fib-4 on Cirrhosis, and Clinical Implications of Noninvasive Score Discordance in a Veteran Cohort

2025-12-02

Abstract excerpt

<title>Abstract</title> <p>Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease in the United States. Noninvasive fibrosis scores, particularly Fibrosis-4 (Fib-4) and the NAFLD fibrosis score (NFS), guide risk stratification, yet their independent contributions and potential discordance in clinical practice remain poorly characterized....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9b197ab8-56f0-5164-86f1-9336b758f63c
DOI: 10.21203/rs.3.rs-8095793/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolic and Clinical Heterogeneity in MASLD Risk Stratification: Independent Effects of Body Mass Index and Fib-4 on Cirrhosis, and Clinical Implications of Noninvasive Score Discordance in a Veteran CohortDOI 10.21203/rs.3.rs-8095793/v1Read

Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients With MASLD: Results From the OBREDI-TR StudySemantic proximity Read

Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver diseaseSemantic proximity Read

Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity Read

FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity Read

Inter-Organ Crosstalk in MASLD: A Narrative ReviewSemantic proximity Read

Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with Metabolically Dysfunction Associated Steatotic Liver DiseaseSemantic proximity Read

Sex-specific lipid-mediated mechanisms drive MASLD progression revealed by paired liver–blood multi-omicsSemantic proximity Read

Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control studySemantic proximity Read

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read

Impact Of Thyroid Dysfunction And Diabetes On Fibrosis And Steatosis Stages In Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read

Global molecular landscape of early MASLD progression in obesitySemantic proximity Read